“…It has been reported repeatedly that the human prostate contains a specific progestin-binding component which shows high affinity and low capacity binding with progestational steroids (Cowan et al, 1977, Shoran and Boesel, 1978, Nozumi et al, 1981. The binder has a similar Kd (dissociation constant) and sedimentation coefficient on sucrose gradient centrifugation to those of the progesterone receptor in the human uterine endometrium (Robel et al, 1981) and in the breast cancer (Horwitz et al, 1985), therefore, the binder in the human prostate has been assumed to be the progesterone receptor per se (Gustafsson et al, 1978, Ekman et al, 1982, Bashirelahi et al, 1983, Schneider et al, 1984.…”